基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 4,733.68
成立日期: 26/01/2004
 
分析
市值分佈:
95.66%
大市值
2.86%
中市值
0.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:00) 總持有投資項目: 405  
0%
 
100%
     10大 (50.46%)
代號 名稱 佔比% 持有日期
NKTRNektar Therapeutics0.0331/03/2026
KNSAKiniksa Pharmaceuticals International, plc0.0331/03/2026
ADUSAddus HomeCare Corp0.0331/03/2026
CRVLCorVel Corp0.0331/03/2026
EWTXEdgewise Therapeutics0.0331/03/2026
AUPHAurinia Pharmaceuticals0.0331/03/2026
INVAInnoviva0.0331/03/2026
VCELVericel Corp0.0331/03/2026
ADPTAdaptive Biotechnologies Corp0.0331/03/2026
OGNOrganon & Co0.0331/03/2026
IRONDisc Medicine0.0331/03/2026
VERAVera Therapeutics0.0231/03/2026
SLNOSoleno Therapeutics0.0231/03/2026
AXGNAxogen0.0231/03/2026
DFTXDefinium Therapeutics Inc0.0231/03/2026
PACSPACS Group0.0231/03/2026
OMCLOmnicell0.0231/03/2026
PRGOPerrigo Company PLC0.0231/03/2026
AORTArtivion0.0231/03/2026
ARDXArdelyx0.0231/03/2026
  1    2    3    4    5    6    7    8    9   10    11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.